- Anti-tumor intermediates
- Imatinib
- Gefitinib
- Sorafenib
- Lenvatinib
- Erlotinib
- Pazopanib
- Sunitinib
- Nilotinib
- Lapatinib
- Dasatinib
- Vandetanib
- Afatinib
- Axitinib
- Ibrutinib
- Palbociclib
- Niraparib
- Acalabrutinib
- Brigatinib
- Olaparib
- Ceritinib
- Canertinib
- Crizotinib
- Osimertinib (AZD9291)
- Bosutinib
- Nidanib
- Alectinib
- Neratinib
- Rucaparib
- Cabozantinib
- Dabrafenib
